Table 2. Cytoplasmic CD73 staining in prostate tissue samples as compared to clinical data.
|
Comparison |
Cytoplasmic CD73 immunostaining |
||
|
Results |
P value |
||
|
Benign vs. malignant |
Increased in cancer |
0.0344 |
|
|
Gleason score |
Reduced in high Gleason scores |
ANOVA test |
0.0072 |
|
Moderate Gleason score vs. low Gleason score |
0.5397 |
||
|
High Gleason score vs. low Gleason score |
0.0081 |
||
|
High Gleason score vs. Moderate Gleason score |
0.0469 |
||
|
Stage (T) |
Higher in T3-4 vs T1-2 |
0.0144 |
|
|
Stage (M) |
No significant difference |
0.8191 |
|
|
Stage (N) |
No significant difference |
0.9650 |
|